Health-Related Quality of Life and Quality of Sexual Life in Obese Subjects

Table 1

Demographic and clinical characteristics.

	Total sample	Males	Females	𝑃
Population Study (no.)	95	25	70
Age (years)	44.2±13.5	41.1±13.9	45.3±13.3	**
BMI (Kg/m^2)	41.2±8.2	43.9±11.0	40.3±6.4	*
Waist circumference (cm)	118.4±14.3	131.4±20.2	113.8±12.1	**
Fat mass—BIA (%)	43.9±4.8	39.8±6.0	45.4±4.3	**
Fat mass—anthropometry (%)	44.3±6.2	40.2±8.5	45.8±5.8	*
Obesity-related diseases
Type 2 diabetes mellitus (no.)	10	4	6
Cardiovascular disease (no.)	10	3	7
Hypertension (no.)	31	8	23
Osteoarticular disease (no.)	40	9	31
Respiratory disease (no.)
Total (no.)	28	8	20
OSAS (no.)	19	6	13
Hypogonadism (no.)	3	3
Medications
CPAP therapy (no.)	5	1	4
ACE inhibitors (no.)	9	2	7
ARB (no.)	13	4	9

^∗𝑃<0.05; ^∗∗𝑃<0.01.
BMI: body mass index; Fat mass—anthropometry: assessed by the measurement of skinfold thicknesses (Lohman et al. [23]); fat mass—BIA: assessed through bioimpedance electric analysis; OSAS: obstructive sleep apnea syndrome; ACE: angiotensin converting enzyme; ARB: angiotensin II receptor blockers; CPAP: continuous positive airway pressure.